IP Verse

Pharmaceutical Compositions Comprising Hydromorphone And Naloxone - EP2568967B2

PatentPatent Analysis

EP2568967

EURO CELTIQUE
Application Number
EP11718747A
Filing Date
May 10, 2011
Status
Patent Maintained As Amended
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3578173B1
EP2706982B2
EP3024461B1

Bibliography

The patent EP2568967B2 was granted to Euro Celtique on Jul 27, 2022 following the initial filing on May 10, 2011 under the application number EP11718747A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NEIDLEINJul 24, 2019 -
ALGOBATEJul 23, 2019 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents